Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

324 Press Releases
DateTitleCompany
17 Jan 17 Sanofi: SuliquaTM Approved in the European Union for the Treatment of Adults with Type 2 Diabetes Sanofi,
Published by
GlobeNewswire
06 Jan 17 Sanofi and Regeneron to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection Sanofi,
Published by
GlobeNewswire
04 Jan 17 Sanofi Announces Soliqua(TM) 100/33 Now Available in the U.S. Sanofi ,
Published by
PharmiWeb.com
04 Jan 17 Sanofi Announces Soliqua(TM) 100/33 Now Available in the U.S. Sanofi,
Published by
GlobeNewswire
03 Jan 17 Sanofi and Boehringer Ingelheim confirm Closing of business swap on January 1st 2017 Sanofi ,
Published by
PharmiWeb.com
02 Jan 17 Sanofi : Reporting EN Sanofi,
Published by
GlobeNewswire
02 Jan 17 Sanofi Pasteur and MSD end joint vaccines business in Europe Sanofi,
Published by
GlobeNewswire
02 Jan 17 Sanofi and Boehringer Ingelheim confirm Closing of business swap on January 1st 2017 Sanofi,
Published by
GlobeNewswire
20 Dec 16 Sanofi Genzyme Announces Recipients of 2016 Patient Advocacy Leadership (PAL) Awards Sanofi Genzyme,
Published by
Business Wire
12 Dec 16 Sanofi :Disclosure of trading in own shares Sanofi,
Published by
GlobeNewswire
08 Dec 16 Sanofi and Regeneron Announce Marketing Authorization Application for Dupixent® (dupilumab) Accepted for Review by the EMA Sanofi,
Published by
GlobeNewswire
05 Dec 16 Sanofi Genzyme Announces Start of Phase III Study of Isatuximab for Relapsed and Refractory Multiple Myeloma Sanofi Genzyme,
Published by
Business Wire
28 Nov 16 Sanofi: Disclosure of trading in own shares Sanofi,
Published by
GlobeNewswire
22 Nov 16 Sanofi Receives FDA Approval of Soliqua™ 100/33 for the Treatment of Adults with Type 2 Diabetes Sanofi ,
Published by
PharmiWeb.com
22 Nov 16 Sanofi Receives FDA Approval of Soliqua(TM) 100/33, for the Treatment of Adults with Type 2 Diabetes Sanofi,
Published by
GlobeNewswire
17 Nov 16 Sanofi and Regeneron Announce Praluent® (alirocumab) Cardiovascular Outcomes Trial will Continue as Planned Following Interim Analysis Sanofi,
Published by
GlobeNewswire
16 Nov 16 Sanofi: Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16... Sanofi,
Published by
GlobeNewswire
11 Nov 16 Sanofi Receives CHMP Recommendation for Approval of SuliquaTM in the EU Sanofi,
Published by
GlobeNewswire
26 Sep 16 Sanofi : BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika Sanofi,
Published by
GlobeNewswire
06 Oct 16 BARDA Awards $37.6 million Contract to Sanofi to Supply Leukine® (sargramostim) for Potential Public Health Emergency Sanofi Genzyme,
Published by
Business Wire
27 Oct 16 Sanofi Pasteur, Fiocruz, and WRAIR Agree to Collaborate on Zika Vaccine Research Sanofi,
Published by
GlobeNewswire
19 Sep 16 Sanofi Files Suit in U.S. to Defend Paten Rights on Lantus® and Lantus® Solostar® Sanofi,
Published by
GlobeNewswire
07 Nov 16 Sanofi : Disclosure of trading in own shares Sanofi,
Published by
GlobeNewswire
30 Sep 16 Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer HealthCare Sanofi,
Published by
GlobeNewswire
22 Sep 16 Data on Treatment Effects with Lemtrada® (alemtuzumab) Over Six Years in People with Relapsing Remitting Multiple Sclerosis to be presented at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in London Sanofi Genzyme
26 Sep 16 Sanofi and Regeneron Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA Sanofi,
Published by
GlobeNewswire
04 Nov 16 Sanofi Genzyme Begins Pivotal Phase 3 Trial of NeoGAA Investigational Second-Generation Therapy for Pompe Disease Sanofi Genzyme,
Published by
Business Wire
28 Oct 16 Sanofi : Sanofi and Regeneron Receive Complete Response Letter from FDA for Sarilumab, an Investigational Treatment for Rheumatoid Arthritis Sanofi,
Published by
GlobeNewswire
13 Oct 16 High-Dose Influenza Vaccine with Evidence of Superior Efficacy* in Older Adults: Now in Canada Sanofi Pasteur,
Published by
PR Newswire
27 Sep 16 BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika Sanofi ,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.